A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Neoplasms|Breast Cancer
Interventions: DRUG: PF-06650808|DRUG: PF-06650808
Sponsor: Pfizer